Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
ConZip, Durela, tramadol extended-release (formerly Cip-tramadol ER)
print preview
bookmark
share with colleague
General Information
Company
Cipher Pharmaceuticals Inc.
Description
Once-daily sustained-release formulation of tramadol
Molecular Target
Mu opioid receptor (OPRM1) (MOR)
Mechanism of Action
Mu opioid receptor agonist
Latest Stage of Development
Approved
Indication
Pain
Partner
Vertical Pharmaceuticals Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information